Skip to content
Close

Regenerative

Stem Cell Therapy in Miami

Stem cell therapy uses products made from human cells or tissue. At Organic Well, stem cell therapy for orthopedic, wound-care and pain conditions is considered only after Elizabeth Isalguez, M.D., evaluates you and explains the evidence, the risks and the alternatives. Florida law allows non-FDA-approved stem cell therapy only in these three areas, and no stem cell product is FDA-approved for orthopedic, pain or wound use. Individual results vary. Evaluation takes place at the clinic in Coconut Grove, Miami.

In-clinic in Coconut Grove and via telehealth across Florida · (305) 930-8891

Last updated:

Key takeaways

  • Meta-analyses of intra-articular MSC injection for knee osteoarthritis report benefit in pain and function, with conflicting results across trials.
  • Cartilage regeneration in humans remains unproven; improvements are measured in symptoms, not imaging.
  • No stem cell product is FDA-approved for orthopedic, pain or wound use.
  • Candidacy is decided in consultation, and "no" is a common, legitimate answer.
  • Insurance does not cover cellular therapy; all costs are disclosed in advance.

What the evaluation covers

Evidence review

What published trials show for your condition, including where results are mixed.

Physician-led planning

Candidacy, sourcing, and protocol are reviewed with you in detail.

Integrated follow-up

Structured follow-up: pain and function are measured at set points and recorded in your chart.

What stem cell therapy is

Stem cell–based therapy uses cellular products, most commonly mesenchymal stem or stromal cells. This page covers orthopedic, wound-care and pain conditions, the only areas in which Florida law allows non-FDA-approved stem cell therapy. The clinical evidence is mixed, the regulatory picture is strict, and the claims made about it are often stronger than the evidence.

At Organic Well, cellular therapy is considered only after a physician evaluation, with a transparent discussion of evidence, expectations, regulatory status and alternatives that may serve you better.

How it works, step by step

  1. Consultation: history, imaging and prior treatments reviewed, and a realistic goal established.
  2. Candidacy assessment: joint stage, comorbidities, medications and expectations all factor in.
  3. Evidence and regulatory briefing: what is FDA-approved, what is not, and what the trial data show for your indication.
  4. Protocol planning: sourcing, preparation, timing and follow-up documented in writing.
  5. Structured follow-up: function and symptoms tracked at 3, 6 and 12 months within your wider plan.

Who it's for, and who it isn't

May be discussed: adults with a joint or soft-tissue problem that has not improved with an adequate trial of standard care (exercise therapy, weight management, medication or injections), who want to understand every option, including surgery.

Not appropriate: patients with active malignancy or infection, advanced bone-on-bone joint disease where the realistic answer is surgical, and anyone who has been promised a specific result elsewhere. If a clinic guarantees an outcome from cellular therapy, that is a reason to leave.

What to expect at your first visit

A long conversation, not a procedure. We review your imaging, examine the joint in question, and lay out every option, including the unglamorous ones that often outperform injections: loading programs, weight management and targeted rehabilitation. If cellular therapy remains on the table, you leave with written information and time to think.

Safety, side effects and contraindications

Side effects depend on the product, the dose and how it is given. Serious harms, including infections, have been reported with unapproved cell products, and the FDA has warned the public about them. We explain the known risks of your specific treatment in writing before you decide.

Contraindications include active cancer, active joint or systemic infection, uncontrolled bleeding disorders and pregnancy. No stem cell product is FDA-approved for orthopedic, pain or wound use.

Pricing and insurance

Cellular therapies are not covered by insurance, and Organic Well does not participate with insurance plans in any case. Costs are disclosed in full before you decide, with no pressure to book on the day.

Stem cell therapy in Coconut Grove, Miami

South Florida has become a hub for regenerative medicine marketing, which makes physician oversight all the more valuable. Our clinic at 3661 S. Miami Ave, Suite 1003 serves patients across Miami-Dade, and we are equally willing to tell you that a cellular therapy is not indicated for your case.

Further reading

Evidence

What the research says

Peer-reviewed sources, quoted directly, including where the evidence is thin.

  • The pooled SMD in the WOMAC score at 12 months was –1.35 (95% CI: –1.97 to –0.74), indicating a moderate to large treatment effect.

    Rahmadian R et al. Efficacy of a single intra-articular injection of mesenchymal stem cells for knee osteoarthritis. Journal of Orthopaedic Surgery and Research, 2025.

    Eight treatment arms from six randomized trials, 300 patients.

  • We included 16 trials (807 participants).

    Mesenchymal stem cells for chronic knee pain secondary to osteoarthritis. Osteoarthritis and Cartilage, 2024.

    A larger, GRADE-assessed synthesis: probably little to no improvement in pain or physical function (moderate certainty).

  • Several MSC-based clinical trials have failed on primary end points, causing many to question whether these stem cells should continue to be studied.

    Tian X et al. Relative efficacy and safety of mesenchymal stem cells for osteoarthritis. Frontiers in Endocrinology, 2024.

    The candid summary of why this field remains contested.

Our position

Some trials report symptom improvement and others do not, and much of the improvement may be a placebo effect. We treat cellular therapy as an option to be discussed, not a product to be sold.

Frequently asked questions

In-clinic in Coconut Grove and via telehealth across Florida · (305) 930-8891

Candidacy is determined in a medical consultation based on your history, imaging or labs where relevant, and your goals. Many patients who ask are better served by other treatments.

No. No stem cell product is FDA-approved for orthopedic, pain, wound, cosmetic or anti-aging use. The stem cell products the FDA has approved are all for serious blood, immune or inherited diseases: blood-forming stem cell products (most of them from umbilical cord blood), gene therapies made from a patient's own blood-forming stem cells (for example, for sickle cell disease), and one mesenchymal stromal cell product (Ryoncil, approved December 2024) for a transplant complication in children. Florida law allows physicians to offer some non-FDA-approved stem cell therapies only for orthopedics, wound care and pain management, with a required notice and a signed consent form.

After evaluation, your physician outlines the protocol, preparation and follow-up schedule specific to your plan, in writing, before anything is scheduled.

Structural cartilage regeneration in humans remains unproven. Trials that show benefit generally show it in pain and function scores, not in cartilage thickness on imaging.

Where benefit occurs, most trials measure it at 6 and 12 months. Anyone promising results in days is overstating the evidence.

It depends on the product and how it is given. Your physician explains what to expect during and after treatment, including discomfort and recovery time, before you decide.

Source, processing and dose vary widely between products and are a major reason trial results conflict. We discuss the specific product, its origin and its documentation with you.

Side effects depend on the product and how it is given. Serious risks, such as infection or a reaction to the product, are real, and the FDA has warned the public about serious harms from unapproved cell products.

No. Costs are disclosed before you decide.

We will say so and redirect you to rehabilitation, metabolic and weight work, hormone optimization, or an orthopedic referral. That is a legitimate outcome of the consultation.

Regulatory note: no stem cell product is FDA-approved for orthopedic, pain or wound use. Florida law (s. 458.3245, F.S.) allows physicians to offer some non-FDA-approved stem cell therapies only for orthopedics, wound care and pain management, with a required notice and a signed consent form. State law does not change FDA rules. Individual results vary.

Contact

Send us a message

Share a few details and our team will reach out within one business day.

What happens next

  1. Our team reaches out within one business day to understand your goals.
  2. We schedule your initial consultation, in clinic or via telehealth.
  3. Your physician builds a personalized plan and we take the first step together.

Visit us

3661 S. Miami Ave, Suite 1003Miami, FL 33133 · United States By appointment · Mon–Fri, 9 AM – 6 PM Care in English, Spanish and French.

Your contact details

I'm interested in

Anything else we should know? (optional)

For example, the best time to call. Please don’t include medical details.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.